Bayer Healthcare Pharmaceuticals Inc. recalls VITRAKVI (larotractenib) oral solution
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Microbial Contamination of Non-Sterile Products: microbial contamination identified as Penicillium brevicompactum observed during routine ongoing stability testing
- Products
-
- VITRAKVI (larotractenib) oral solution
- Company
- Bayer Healthcare Pharmaceuticals Inc.
- Where it was sold
-
Product was distributed to specialty pharmacies and distributors nationwide who may have further distributed the product.
Nationwide
- Units affected
- 192 bottles
- About this recall
- VITRAKVI (larotractenib) oral solution, 20mg/mL, 100 mL bottle, Rx only, Manufactured for Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ 07981. NDC 50419-392-01